A detailed history of Avion Wealth transactions in Catalent, Inc. stock. As of the latest transaction made, Avion Wealth holds 8 shares of CTLT stock, worth $507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$507
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$56.16 - $60.96 $449 - $487
8 New
8 $0
Q3 2023

Oct 20, 2023

BUY
$44.2 - $50.2 $442 - $502
10 New
10 $0
Q2 2020

Jul 29, 2020

SELL
$48.02 - $79.04 $5,618 - $9,247
-117 Closed
0 $0
Q1 2020

Apr 08, 2020

BUY
$36.95 - $62.95 $4,323 - $7,365
117 New
117 $6,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.